Cygna Labs Announces the General Availability of VitalQIP 24
Saturday, December 14, 2024
Enhancement release enables Cygna Labs customers to holistically manage DDI across enterprise networks, data centers, and multi-cloud deployments
MIAMI, Dec. 12, 2024 /PRNewswire-PRWeb/ -- Cygna Labs, a highly specialized software developer focused on providing enterprises worldwide and a leading provider of DDI, cloud security, and compliance technology solutions, announced today the availability of VitalQIP 24. As the second major release of VitalQIP since Cygna Labs acquired the product, VitalQIP 24 demonstrates Cygna Labs' ongoing commitment to its customers.
The VitalQIP 24 release was developed with an emphasis on automation and cloud enhancements. The release expands REST API support to facilitate automation and integration, extends cloud DNS support to include the ability to modify AWS Route 53 and Azure DNS zone data, and enhances cloud-to-non-cloud networking for added DNS resiliency. These features and the many additional customer-requested enhancements included in VitalQIP24 enable Cygna Labs customers to holistically manage DDI across enterprise networks, data centers, and multi-cloud deployments.
Alexander Haecker, CEO of Cygna Labs Group GmbH, stated, "Cygna Labs continues to deliver on its commitment to investing in enhancing and evolving VitalQIP. We aim to enable customers to manage their IP address space and associated DHCP and DNS configurations more effectively and efficiently."
About Cygna Labs Cygna Labs is a software developer and one of the top three global DDI vendors. Many Fortune 100 customers rely on Cygna Labs' DDI products and services, in addition to its industry-leading security and compliance solutions, to detect and proactively mitigate data security threats, affordably pass compliance audits, and increase the productivity of their IT departments. For more information, visit https://cygnalabs.com.
Media Contact
Kim Dearborn, Cygna Labs Corp., 1 3056005215, pr@cygnalabs.com, https://cygnalabs.com
View original content:https://www.prweb.com/releases/cygna-labs-announces-the-general-availability-of-vitalqip-24-302328616.html
SOURCE Cygna Labs Corp.
|
|
|
|
|
 |
Asetek - Mandatory Notification of Trade | Jan 22, 2026
|
|
Tomorrowland Brings the Magic to Shanghai for a Spectacular First Indoor Edition in China | Jan 22, 2026
|
|
BC.GAME to Host "Stay Untamed" Night During Abu Dhabi's Packed Web3 Summit Week | Jan 22, 2026
|
|
Rent Manager Earned Best Real Estate Software Product Award and Multiple Review Badges from G2 Platform | Jan 22, 2026
|
|
Auburn University's Applied Research Institute Expands Advanced Manufacturing Capabilities with CF3D Enterprise Cell | Jan 22, 2026
|
|
AMPERA ANNOUNCES LOCATION FOR GLOBAL HEADQUARTERS | Jan 22, 2026
|
|
Gemmy Alerts Customers: Fake Websites Target Holiday Decorators | Jan 22, 2026
|
|
California Divorce Mediation Center Unveils Modern Website Redesign | Jan 22, 2026
|
|
Culture and tourism sectors thrive in Xiamen | Jan 22, 2026
|
|
AMPLIFY Named Finalist in Three Categories at the 2026 Golden Gavel Awards | Jan 22, 2026
|
|
|
